Monoclonal antibodies cannot be used for post-exposure prophylaxis of COVID-19.

The transmission of COVID-19 is effectively prevented by usual protective equipment and clothing.

There are multiple pathogenetic targets for treatment of SARS-CoV-2 infection.

The size of SARS-CoV-2 viral particles is within the nanoscale range.

Remdesivir is indicated for use in patients with mild-to-moderate disease.

Leave a Reply